Latest News

Ian Flinn, MD, PhD: Bruton's Tyrosine Kinase Therapy Offers Fewer Adverse Events for CLL, SLL
Ian Flinn, MD, PhD: Bruton's Tyrosine Kinase Therapy Offers Fewer Adverse Events for CLL, SLL

January 30th 2023

Dr. Ian Flinn explains that as a Bruton's tyrosine kinase (BTK) therapy, zanubrutinib provides an option with reduced adverse events compared with chemotherapy treatments like venetoclax.

CVD-Related Deaths Surged During First Year of COVID-19 Pandemic
CVD-Related Deaths Surged During First Year of COVID-19 Pandemic

January 30th 2023

Biomarker Predicts Patients at Greater Risk of Worsening Knee Osteoarthritis
Biomarker Predicts Patients at Greater Risk of Worsening Knee Osteoarthritis

January 30th 2023

Air Pollution in Urban Areas Linked to Asthma, Inflammatory Responses in Children
Air Pollution in Urban Areas Linked to Asthma, Inflammatory Responses in Children

January 30th 2023

Aerobic Exercise Programs May Help Prevent Diabetes in Individuals with Obesity
Aerobic Exercise Programs May Help Prevent Diabetes in Individuals with Obesity

January 30th 2023

Conference Coverage

View All
Jennifer Crosbie, PhD: A Video Game Platform for Improving Executive Function
Jennifer Crosbie, PhD: A Video Game Platform for Improving Executive Function

January 30th 2023

Katie Falloon, MD: Studying IBD-Associated Peripheral Arthritis
Katie Falloon, MD: Studying IBD-Associated Peripheral Arthritis

January 24th 2023

Brad Pasternak, MD: Treating Pediatric COVID-19 Patients With IBD With Paxlovid
Brad Pasternak, MD: Treating Pediatric COVID-19 Patients With IBD With Paxlovid

January 23rd 2023

Kendall Beck, MD: Promising New Tofacitinib Data From the Crohn's and Colitis Congress
Kendall Beck, MD: Promising New Tofacitinib Data From the Crohn's and Colitis Congress

January 21st 2023

Video Series
View All
Video Interviews
View All
Podcasts
View All

All News

© 2023 MJH Life Sciences

All rights reserved.